Clinical Trial Update: UFUR (Tegafur/Uracil) Plus Iressa in Non-small-cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating UFUR (tegafur/uracil) in combination with Iressa (gefitinib) for non-small cell lung cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Iressa (gefitinib)
• UFUR (Tegafur/Uracil) (tegafur/uracil)

Snippet

Sponsor: Taipei Veterans General Hospital, Taiwan | Conditions: Non-Small-Cell Lung Cancer | Phase 2 | Status: COMPLETED